Listed by the USPTO as HIBBERT, CATHERINE S
Tech Center 3700 • Art Units: 1614 1636 1658 1678 3791
This examiner grants 59% of resolved cases
HIBBERT, CATHERINE S has resolved 810 cases in tech center 3700 and art unit 1614. The allowance rate is 58.8%, and the interview lift is 48.6%. The median time to allowance is 1403 days. Interviews are a prominent feature of the recorded outcomes, while the median indicates that matters may require lengthy prosecution.
VIRON, INC., Beam Therapeutics Inc., and Abbott Laboratories are the leading companies. CANTOR COLBURN LLP, McNeill PLLC, and AMSTER, ROTHSTEIN & EBENSTEIN LLP are the listed firms. The company record is concentrated in biotechnology and healthcare, making technical preparation and interview execution especially relevant.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18686840 | IMMUNE CHECKPOINT TARGETING THERAPEUTIC NANOPARTICLES | Non-Final OA | The Regents of the University of California |
| 18185449 | DISCOVERY OF YEATS2 YEATS DOMAIN INHIBITORS AS NOVEL ANTI-CANCER AGENTS | Non-Final OA | The University of Hong Kong |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy58.8% of resolved applications examined by Catherine S Hibbert were allowed (810 resolved cases), compared with 47.9% across Art Unit 1614 over the last five years.
This examiner's interview lift is +48.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Catherine S Hibbert took 1,403 days on average from filing to allowance.
Catherine S Hibbert examines applications in Art Unit 1614 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
